Two recent trials in the UK have looked at the use of pharmaceutical drugs based on cannabis for the treatment of the symptoms of MS. Sativex is an oral spray that contains two ingredients derived from cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD). It has previously shown promise in the treatment of muscle spasticity in the short term. A recent trial in the UK followed people taking Sativex over the longer term. This study was primarily looking to see if taking Sativex was safe over the longer time period and whether increased doses were needed to maintain effectiveness.
Read more at the link below
http://www.msra.org.au/cannabis-based-medications-tested-symptom-relief-ms
http://www.msra.org.au/cannabis-based-medications-tested-symptom-relief-ms
Link: http://www.ozms.org/content/cannabis-based-medications-tested-symptom-relief-ms?utm_source=twitterfeed&utm_medium=twitter
OzMS (OzMS) on Twitter
No comments:
Post a Comment